Back to search

Article

Clinical characteristics and prognostic analysis of 95 cases of recurrent/metastatic nasopharyngeal carcinoma treated with immunotherapy: a single-center retrospective study

2025-08-13

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Immunotherapy has become established as the standard treatment for advanced nasopharyngeal cancer; however, there remains a subset of patients whose outcomes are unsatisfactory. The present study aims to investigate the clinical characteristics and prognostic factors affecting the prognosis of recurrent/metastatic nasopharyngeal carcinoma patients receiving PD-1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
75250a97-4a9c-58af-a8ab-20ed8eba0bc5
DOI
10.21203/rs.3.rs-7111775/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical characteristics and prognostic analysis of 95 cases of recurrent/metastatic nasopharyngeal carcinoma treated with immunotherapy: a single-center retrospective studyDOI 10.21203/rs.3.rs-7111775/v1
Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers: The Early Experience of Two Academic CenterSemantic proximity
Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome expression could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti–programmed cell death 1 monotherapySemantic proximity
Combination of immunotherapy and anti-EGFR agents in immunotherapy refractory head neck cancer recurrent and metastatic head neck squamous cell carcinomaSemantic proximity
Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapySemantic proximity
Plasma Epstein-Barr virus DNA for the prediction of treatment response and disease progression in non-keratinizing differentiated nasopharyngeal carcinomaSemantic proximity
Nasopharyngeal carcinoma at the virology precision oncology nexus: decoding molecular alterations for early intervention and therapeutic innovationSemantic proximity
Nasopharyngeal carcinoma: molecular biomarker discovery and progress.Semantic proximity
The molecular characteristics of recurrent/metastatic HPV-positive head and neck squamous cell carcinoma: A systematic review of the literatureSemantic proximity
Genomic characterization reveals potential biomarkers in nasopharyngeal carcinoma patients with relapse.Semantic proximity
Risk of Second Primary Malignancy in Nasopharyngeal Carcinoma Patients: A Single Center Experience from TürkiyeSemantic proximity
Establishment of an integrated model for predicting survival and guiding treatment in local recurrence nasopharyngeal carcinomaSemantic proximity
A Novel Prognostic Model Predicts Overall Survival in Patients With Nasopharyngeal Carcinoma Based on Clinical Features and Blood BiomarkersSemantic proximity
Select a neighboring publication to make it the new centre.